The Noramco Group Invests $25 Million in Halo Pharma’s Whippany Facility to Offer Sterile Injectable Manufacturing
Press Release The Noramco Group, an integrated North American-based API and drug product supply chain product and services provider, today announced a $25 million investment in its Halo Pharma ...
pharmaphorum3d
Med comms agency 90TEN acquired by Envision Pharma Group
Envision Pharma Group said the deal would also enrich its global reach in medical affairs, while also providing 90TEN’s London-based team with significant geographical expansion opportunities.
China Daily14d
Academician: Battle pancreatic disease to benefit patients, offer 'Oriental Wisdom'
Representing a groundbreaking initiative in pancreatic disease prevention and treatment, the strategic partnership can help CAP and Hengrui Pharma elevate China's healthcare capabilities in ...
pharmaphorum5y
Envision Pharma Group appoints David Thompson as CEO
Scientific communications organisation the Envision Pharma Group has revamped its top team, promoting David Thompson to chief executive officer as Brian Hepburn shifts to become its executive co ...
Contract Pharma6d
The Noramco Group Invests $25M into Halo Pharma Facility in NJ
The Noramco Group is investing $25M into its Halo Pharma facility in Whippany, NJ to establish sterile injectable ...
Morningstar7d
The Noramco Group Invests $25 Million in Halo Pharma’s Whippany Facility to Offer Sterile Injectable Manufacturing
Learn More About Halo Pharma’s New Sterile Manufacturing Capabilities at DCAT Week 2025— The Noramco Group, an integrated North American-based API and drug product supply chain product and ...
Business Wire7d
The Noramco Group Invests $25 Million in Halo Pharma’s Whippany Facility to Offer Sterile Injectable Manufacturing
The Noramco Group’s investment will provide branded and generic pharmaceutical companies with a North American-based solution for sterile injectable manufacturing, strengthening the domestic ...